These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23478621)

  • 21. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated systematic review of the approach to pelvic exenteration for locally advanced primary rectal cancer.
    Fahy MR; Hayes C; Kelly ME; Winter DC
    Eur J Surg Oncol; 2022 Nov; 48(11):2284-2291. PubMed ID: 35031157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Indications and outcome of pelvic exenteration for locally advanced primary and recurrent rectal cancer.
    Bhangu A; Ali SM; Brown G; Nicholls RJ; Tekkis P
    Ann Surg; 2014 Feb; 259(2):315-22. PubMed ID: 23478530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic exenteration for men with locally advanced rectal cancer: a morbidity analysis of complicated cases.
    Hsu TW; Chiang FF; Chen MC; Wang HM
    Asian J Surg; 2011 Jul; 34(3):115-20. PubMed ID: 22208686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer.
    Gould LE; Pring ET; Drami I; Moorghen M; Naghibi M; Jenkins JT; Steele CW; Roxburgh CS
    Int J Surg; 2022 Aug; 104():106738. PubMed ID: 35781038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical salvage of recurrent rectal cancer after transanal excision.
    Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
    Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    PelvEx Collaborative
    Br J Surg; 2018 May; 105(6):650-657. PubMed ID: 29529336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvic exenteration for recurrent rectal cancer.
    Avradopoulos KA; Vezeridis MP; Wanebo HJ
    Adv Surg; 1996; 29():215-33. PubMed ID: 8720005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Total pelvic exenteration with preoperative irradiation for advanced primary and recurrent rectal cancer.
    Wiig JN; Poulsen JP; Larsen S; Braendengen M; Waehre H; Giercksky KE
    Eur J Surg; 2002; 168(1):42-8. PubMed ID: 12022371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
    Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
    ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 10-year experience of total pelvic exenteration for primary advanced and locally recurrent rectal cancer based on a prospective database.
    Nielsen MB; Rasmussen PC; Lindegaard JC; Laurberg S
    Colorectal Dis; 2012 Sep; 14(9):1076-83. PubMed ID: 22107085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended surgery and pelvic exenteration for locally advanced rectal cancer. What are the limits?
    Smith JD; Paty PB
    Acta Chir Iugosl; 2010; 57(3):23-7. PubMed ID: 21066979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of pelvic exenteration in the management of recurrent rectal cancer.
    Kakuda JT; Lamont JP; Chu DZ; Paz IB
    Am J Surg; 2003 Dec; 186(6):660-4. PubMed ID: 14672775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.
    PelvEx Collaborative
    BJS Open; 2019 Aug; 3(4):516-520. PubMed ID: 31388644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic exenterations for primary rectal cancer: Analysis from a 10-year national prospective database.
    Pellino G; Biondo S; Codina Cazador A; Enríquez-Navascues JM; Espín-Basany E; Roig-Vila JV; García-Granero E;
    World J Gastroenterol; 2018 Dec; 24(45):5144-5153. PubMed ID: 30568391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transperineal retropubic approach in total pelvic exenteration for advanced and recurrent colorectal and anal cancer involving the penile base: technique and outcomes.
    Mehta AM; Hellawell G; Burling D; Littler S; Antoniou A; Jenkins JT
    Tech Coloproctol; 2018 Sep; 22(9):663-671. PubMed ID: 30306276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
    PelvEx Collaborative
    Ann Surg; 2019 Feb; 269(2):315-321. PubMed ID: 28938268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of recurrence following pelvic exenteration and external radiotherapy for locally advanced primary rectal adenocarcinoma.
    Luna-Perez P; Delgado S; Labastida S; Ortiz N; Rodriguez D; Herrera L
    Ann Surg Oncol; 1996 Nov; 3(6):526-33. PubMed ID: 8915483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of laparoscopic-assisted transanal pelvic exenteration in locally advanced rectal cancer with anterior invasion.
    Nonaka T; Tominaga T; Akazawa Y; Sawai T; Nagayasu T
    Tech Coloproctol; 2021 Jan; 25(1):69-74. PubMed ID: 32815047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.